Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Frontiers in Medicine|July 9, 2019
Synovial Tissue Biopsy Collection by Rheumatologists: Ready for Clinical Implementation?Marijn Smits, Sebastiaan van de Groes, Rogier M ThurlingsArthritis and Rheumatism|November 28, 2008
Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial respondersRogier M Thurlings, Koen Vos, Daniëlle M Gerlag, et al.Biomedicines|February 25, 2022
Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated FibrosisTheodoros-Ioannis Papadimitriou, Arjan van Caam, Peter M van der Kraan, et al.International Journal of Molecular Sciences|September 22, 2019
Linkage of Periodontitis and Rheumatoid Arthritis: Current Evidence and Potential Biological InteractionsRafael Scaf de Molon, Carlos Rossa, Rogier M Thurlings, et al.Arthritis and Rheumatism|March 1, 2007
Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritisKoen Vos, Rogier M Thurlings, Carla A Wijbrandts, et al.BMC Primary Care|August 1, 2023
Diagnosing knee osteoarthritis in patients, differences between general practitioners and orthopedic surgeons: a retrospective cohort studyBob J Evers, Henk J Schers, Cornelia H M van den Ende, et al.Annals of the Rheumatic Diseases|November 11, 2011
Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesisMaria J H Boumans, Rogier M Thurlings, Lorraine Yeo, et al.Arthritis and Rheumatism|October 31, 2009
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective studyRuth Klaasen, Rogier M Thurlings, Carla A Wijbrandts, et al.Journal of Personalized Medicine|July 27, 2026
Available Biomarkers for Personalized Prognostication in Early and Very Early Systemic Sclerosis: A Narrative Review of the Current LiteratureIsabel Dirven, Marre W Kamminga, Lise M Verhoef, et al.Rheumatology (Oxford, England)|January 7, 2021
The role of inflammation in mesenchymal stromal cell therapy in osteoarthritis, perspectives for post-traumatic osteoarthritis: a reviewWessel F Theeuwes, Martijn H J van den Bosch, Rogier M Thurlings, et al.Pageof 5